Glanbia plc
GLAPY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.6B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.60 Billion |
|---|---|
| Enterprise Value | $6.43 Billion |
| Annual dividend | $2.28 |
| Dividend yield | 2.20% |
| Earnings per Share | $3.65 |
| Beta | 0.5 |
| Outstanding Shares | 48,302,645 |
Return
| Return on Equity | 18.73% |
|---|---|
| Return on Assets | 8.89% |
| Return on Invested Capital | 21.24% |
Valuation & Multiples
| P/E Ratio | 23.14 |
|---|---|
| PEG | 44.83 |
| Price to Sales | 0.65 |
| Price to Book Ratio | 2.78 |
| Enterprise Value to Revenue | 0.79 |
| Enterprise Value to EBIT | 10.4 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.64 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$3.51
Consensus analyst estimateRevenue Estimate
$2.02 B
Consensus analyst estimateNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
$3.93
Consensus analyst estimateRevenue Estimate
$2.15 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Glanbia plc
4,963 employees
CEO: Hugh McGuire Finance
Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-...